Dashboard
Manage Tickers

ACIUAC Immune SA

Nasdaq acimmune.com


$ 3.39 $ -0.12 (-3.42 %)    

Thursday, 16-May-2024 15:59:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.64 $ -1.83 (-0.4 %)
DIA $ 399.14 $ -0.07 (-0.02 %)
SPY $ 528.49 $ -1.29 (-0.24 %)
TLT $ 92.06 $ -0.04 (-0.04 %)
GLD $ 220.06 $ -0.83 (-0.38 %)
$ 3.41
$ 3.43
$ 3.39 x 100
$ 6.50 x 300
$ 3.33 - $ 3.48
$ 1.90 - $ 5.14
1,010,851
na
348.18M
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dlocal-allogene-therapeutics-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DLocal, Allogene Therapeutics And Other Bi...
05/15/2024 10:12:21

gold-down-over-1-ac-immune-shares-spike-higher
Gold Down Over 1%; AC Immune Shares Spike ...
05/13/2024 18:32:51

why-is-small-cap-alzheimers-focused-ac-immune-stock-trading-higher-on-monday
Why Is Small-Cap Alzheimer's-Focused AC Im...
05/13/2024 17:46:29

Unlocking hope for Alzheimer's with ACI-24.060. Takeda's agreement with AC Immune targets toxic forms of Abeta, potenti...

why-akoustis-technologies-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Akoustis Technologies Shares Are Tradi...
05/13/2024 17:01:38

crude-oil-surges-over-1-amprius-technologies-shares-plunge
Crude Oil Surges Over 1%; Amprius Technolo...
05/13/2024 16:00:55

Core News & Articles
Market-Moving News for May 13th
05/13/2024 12:42:15

GME: 46% | GameStop shares are trading higher amid possible retail investor interest following a social media post by Roaring K...

ac-immune-expects-three-year-cash-runway-with-cash-balance-of-chf-1048m-at-q1-end-plus-100m-upfront-from-takeda-and-the-anticipated-aci-35030-related-chf-25m-milestone
AC Immune Expects Three-Year Cash Runway W...
05/13/2024 10:14:12

ac-immune-q1-2024-gaap-eps-chf018-misses-chf014-estimate
AC Immune Q1 2024 GAAP EPS CHF(0.18) Misse...
05/13/2024 10:13:14

Core News & Articles
AC Immune And Takeda Sign Exclusive Option...
05/13/2024 10:06:21

hc-wainwright--co-reiterates-buy-on-ac-immune-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on AC I...
03/15/2024 10:41:59

HC Wainwright & Co. analyst Andrew Fein reiterates AC Immune (NASDAQ:ACIU) with a Buy and maintains $16 price target.

ac-immune-sa-reported-fy23-revenue-of-chf1480m-vs-chf394m-yoy-eps-loss-of-chf064-vs-chf085-yoy-cash-balance-of-chf1031m
AC Immune SA Reported FY23 Revenue of CHF1...
03/14/2024 11:17:56

ac-immune-received-decision-to-grant-european-patent-ep3735411-1345-tetrahydro-2h-pyrido43-bindole-derivatives-for-the-treatment-alleviation-or-prevention-of-disorders-associated-with-tau-aggregates-like-alzheimers-disease
AC Immune Received Decision To Grant Europ...
02/08/2024 17:37:16

https://register.epo.org/application?number=EP21153153

Core News & Articles
AC Immune Will Regain All Global Rights To...
01/22/2024 12:33:21

ac-immune-says-abate-phase-1b2-ad-trial-of-aci-24060-is-expected-to-complete-cohort-3-in-january-six-month-and-12-month-amyloid-pet-data-expected-in-h1-and-h2-2024-respectively
AC Immune Says ABATE Phase 1b/2 AD Trial O...
01/03/2024 13:12:11

ac-immune-raises-50m-its-alzheimers-targeting-immunotherapy-advances-into-phase-2b-trial
AC Immune Raises $50M, Its Alzheimer's Tar...
12/15/2023 15:58:43

AC Immune SA's (NASDAQ: ACIU) development partner has programmed the launch of a Phase 2b clinical study to evaluate ACI-35...

ac-immune-announces-pricing-of-underwritten-offering-of-143m-of-its-common-shares-at-350-per-share-common-share-company-expects-gross-proceeds-of-501m
AC Immune Announces Pricing Of Underwritte...
12/15/2023 13:00:28

ac-immune-says-its-targeted-anti-ptau-active-immunotherapy-for-alzheimers-disease-advances-into-phase-2b-trial
AC Immune Says Its Targeted Anti-pTau Acti...
12/15/2023 12:24:49

ac-immune-appointed-interim-cfo-christopher-roberts-as-permanent-finance-chief
AC Immune Appointed Interim CFO Christophe...
12/01/2023 12:05:27

AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative dise...

alzheimers-disease-vaccines-promising-developments-renewed-enthusiasm-from-biogen-eli-lilly-and-others
Alzheimer's Disease Vaccines: Promising De...
11/21/2023 20:16:25

Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain...

hc-wainwright--co-reiterates-buy-on-ac-immune-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on AC I...
11/13/2023 15:55:35

HC Wainwright & Co. analyst Andrew Fein reiterates AC Immune (NASDAQ:ACIU) with a Buy and maintains $16 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION